{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:52:44Z","timestamp":1788979964379,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":611,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","award":["Spinocerebellar Ataxia Research Award"],"award-info":[{"award-number":["Spinocerebellar Ataxia Research Award"]}],"id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Landesgraduiertenf\u00f6rderung Baden-W\u00fcrttemberg","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1074\/jbc.ra118.005801","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:17:47Z","timestamp":1542709067000},"page":"644-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Physiological and pathophysiological characteristics of ataxin-3 isoforms"],"prefix":"10.1016","volume":"294","author":[{"given":"Daniel","family":"Weish\u00e4upl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peixoto Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Ruess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Maria","family":"Dold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"von Zweydorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-6944","authenticated-orcid":false,"given":"Christian Johannes","family":"Gloeckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.005801_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado\u2013Joseph Disease","volume":"97","author":"Costa","year":"2012","journal-title":"Prog. Neurobiol"},{"key":"10.1074\/jbc.RA118.005801_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.410410408","article-title":"Machado\u2013Joseph disease gene product is a cytoplasmic protein widely expressed in brain","volume":"41","author":"Paulson","year":"1997","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/nbdi.1998.0208","article-title":"Heterogeneous intracellular localization and expression of ataxin-3","volume":"5","author":"Trottier","year":"1998","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","article-title":"An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients","volume":"8","author":"Schmidt","year":"1998","journal-title":"Brain Pathol"},{"key":"10.1074\/jbc.RA118.005801_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s100380170060","article-title":"The genomic structure and expression of MJD, the Machado\u2013Joseph disease gene","volume":"46","author":"Ichikawa","year":"2001","journal-title":"J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygeno.2004.02.012","article-title":"Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado\u2013Joseph disease (MJD) gene","volume":"84","author":"Costa","year":"2004","journal-title":"Genomics"},{"key":"10.1074\/jbc.RA118.005801_bib7","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1515\/BC.2007.107","article-title":"Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes","volume":"388","author":"Tzvetkov","year":"2007","journal-title":"Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2009.07.020","article-title":"Identification and functional dissection of localization signals within ataxin-3","volume":"36","author":"Antony","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1096\/fj.06-7002com","article-title":"Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado\u2013Joseph disease protein ataxin-3","volume":"21","author":"Rodrigues","year":"2007","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA118.005801_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA118.005801_bib12","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","article-title":"Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation","volume":"26","author":"Evert","year":"2006","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA118.005801_bib13","doi-asserted-by":"crossref","first-page":"29348","DOI":"10.1074\/jbc.M704126200","article-title":"Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity","volume":"282","author":"Todi","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10048-009-0216-y","article-title":"Increased transcript diversity: novel splicing variants of Machado\u2013Joseph disease gene (ATXN3)","volume":"11","author":"Bettencourt","year":"2010","journal-title":"Neurogenetics"},{"key":"10.1074\/jbc.RA118.005801_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado\u2013Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0168-0102(97)00056-4","article-title":"Machado\u2013Joseph disease gene products carrying different carboxyl termini","volume":"28","author":"Goto","year":"1997","journal-title":"Neurosci. Res"},{"key":"10.1074\/jbc.RA118.005801_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12031-012-9832-3","article-title":"Transcript diversity of Machado\u2013Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions","volume":"49","author":"Bettencourt","year":"2013","journal-title":"J. Mol. Neurosci"},{"key":"10.1074\/jbc.RA118.005801_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318184","article-title":"Ancestral origins of the Machado\u2013Joseph disease mutation: a worldwide haplotype study","volume":"68","author":"Gaspar","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013695","article-title":"Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties","volume":"5","author":"Harris","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.005801_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/hmg\/ddu532","article-title":"A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript","volume":"24","author":"Ramani","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib21","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/j.1742-4658.2006.05419.x","article-title":"Ataxin-3 is subject to autolytic cleavage","volume":"273","author":"Mauri","year":"2006","journal-title":"FEBS J"},{"key":"10.1074\/jbc.RA118.005801_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000090035","article-title":"Population genetics of wild-type CAG repeats in the Machado\u2013Joseph disease gene in Portugal","volume":"60","author":"Lima","year":"2005","journal-title":"Hum. Hered"},{"key":"10.1074\/jbc.RA118.005801_bib23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","article-title":"Improvement in the molecular diagnosis of Machado\u2013Joseph disease","volume":"58","author":"Maciel","year":"2001","journal-title":"Arch. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1074\/jbc.RA118.005801_bib25","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/hmg\/dds449","article-title":"Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)","volume":"22","author":"H\u00fcbener","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/brain\/awx039","article-title":"A combinatorial approach to identify calpain cleavage sites in the Machado\u2013Joseph disease protein ataxin-3","volume":"140","author":"Weber","year":"2017","journal-title":"Brain"},{"key":"10.1074\/jbc.RA118.005801_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddi472","article-title":"Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3","volume":"15","author":"Haacke","year":"2006","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib29","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA118.005801_bib30","doi-asserted-by":"crossref","first-page":"E2624","DOI":"10.1073\/pnas.1716071115","article-title":"Karyopherin \u03b1-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3","volume":"115","author":"Sowa","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005801_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado\u2013Joseph disease: clinical, molecular, and neuropathological features","volume":"39","author":"D\u00fcrr","year":"1996","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib32","first-page":"54","article-title":"Correlation between CAG repeat length and clinical features in Machado\u2013Joseph disease","volume":"57","author":"Maciel","year":"1995","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/hmg\/4.6.1001","article-title":"Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in german SCA patients","volume":"4","author":"Sch\u00f6ls","year":"1995","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.20424","article-title":"Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort","volume":"57","author":"van de Warrenburg","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib35","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/mds.22288","article-title":"Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6","volume":"23","author":"Globas","year":"2008","journal-title":"Mov. Disord"},{"key":"10.1074\/jbc.RA118.005801_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/WNL.46.1.4","article-title":"Machado\u2013Joseph disease and SCA3: the genotype meets the phenotypes","volume":"46","author":"Junck","year":"1996","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA118.005801_bib37","first-page":"119","article-title":"A familial factor independent of CAG repeat length influences age at onset of Machado\u2013Joseph disease","volume":"59","author":"DeStefano","year":"1996","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","article-title":"Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism","volume":"18","author":"Warrick","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA118.005801_bib39","doi-asserted-by":"crossref","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","article-title":"Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo","volume":"288","author":"Tsou","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2015.05.010","article-title":"The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster","volume":"82","author":"Tsou","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib41","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/jnr.23395","article-title":"Using membrane-targeted green fluorescent protein to monitor neurotoxic protein-dependent degeneration of Drosophila eyes","volume":"92","author":"Burr","year":"2014","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.RA118.005801_bib42","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/hmg\/ddx039","article-title":"Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of spinocerebellar ataxia type 3","volume":"26","author":"Sutton","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/ejhg.2009.215","article-title":"The (CAG)n tract of Machado\u2013Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls","volume":"18","author":"Bettencourt","year":"2010","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ejhg.5200264","article-title":"Study of three intragenic polymorphisms in the Machado\u2013Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)(n) tract","volume":"7","author":"Maciel","year":"1999","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib45","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005801_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2008.01.011","article-title":"Study of subcellular localization and proteolysis of ataxin-3","volume":"30","author":"Pozzi","year":"2008","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fnmol.2018.00368","article-title":"Mitochondrial morphology, function and homeostasis are impaired by expression of an N-terminal calpain cleavage fragment of ataxin-3","volume":"11","author":"Harmuth","year":"2018","journal-title":"Front. Mol. Neurosci"},{"key":"10.1074\/jbc.RA118.005801_bib48","doi-asserted-by":"crossref","first-page":"26436","DOI":"10.1074\/jbc.M803692200","article-title":"The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains","volume":"283","author":"Winborn","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib49","doi-asserted-by":"crossref","first-page":"D369","DOI":"10.1093\/nar\/gkw1102","article-title":"The BioGRID interaction database: 2017 update","volume":"45","author":"Chatr-Aryamontri","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.RA118.005801_bib50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.emboj.7600081","article-title":"Molecular clearance of ataxin-3 is regulated by a mammalian E4","volume":"23","author":"Matsumoto","year":"2004","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.005801_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA118.005801_bib52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2012.08.011","article-title":"A census of human soluble protein complexes","volume":"150","author":"Havugimana","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.005801_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1097-2765(02)00802-X","article-title":"Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter","volume":"11","author":"Wood","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA118.005801_bib54","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1073\/pnas.201393498","article-title":"Identification of proteins that interact with mammalian peptide:N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradation","volume":"98","author":"Park","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005801_bib55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.embor.7400164","article-title":"A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation","volume":"5","author":"Medicherla","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1074\/jbc.RA118.005801_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/hmg\/ddq452","article-title":"The Machado\u2013Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability","volume":"20","author":"Durcan","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","article-title":"Excitation-induced ataxin-3 aggregation in neurons from patients with Machado\u2013Joseph disease","volume":"480","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.005801_bib58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/sj.ejhg.5201643","article-title":"A multistep mutation mechanism drives the evolution of the CAG repeat at MJD\/SCA3 locus","volume":"14","author":"Martins","year":"2006","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib59","doi-asserted-by":"crossref","unstructured":"Ooms, J., (2017) magick: Advanced Graphics and Image-Processing in R, R package version 1.4.","DOI":"10.59350\/th49p-22b65"},{"key":"10.1074\/jbc.RA118.005801_bib60","doi-asserted-by":"crossref","first-page":"1012.e11","DOI":"10.1016\/j.neurobiolaging.2011.10.030","article-title":"Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases","volume":"33","author":"Mills","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.RA118.005801_bib61","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.96.10.5598","article-title":"Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements","volume":"96","author":"D'Souza","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005801_bib62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib63","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/hmg\/8.8.1529","article-title":"Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer\u2019s disease by increased A\u03b242 secretion","volume":"8","author":"De Jonghe","year":"1999","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib64","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1093\/brain\/123.12.2467","article-title":"Pathology of early-onset Alzheimer\u2019s disease cases bearing the Thr113\u2013114ins presenilin-1 mutation","volume":"123","author":"Singleton","year":"2000","journal-title":"Brain"},{"key":"10.1074\/jbc.RA118.005801_bib65","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/11.22.2787","article-title":"Functional association of the parkin gene promoter with idiopathic Parkinson's disease","volume":"11","author":"West","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"\u03b1-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"Beyer","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1074\/jbc.RA118.005801_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res"},{"key":"10.1074\/jbc.RA118.005801_bib68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nature06731","article-title":"Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1","volume":"452","author":"Lim","year":"2008","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.005801_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1074\/jbc.RA118.005801_bib70","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1046\/j.1471-4159.1999.0722498.x","article-title":"A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue","volume":"72","author":"Sato","year":"1999","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.005801_bib71","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/hmg\/ddp274","article-title":"CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3","volume":"18","author":"Mueller","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib72","article-title":"SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.005801_bib73","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1471-4159.2011.07435.x","article-title":"Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model","volume":"119","author":"Roscic","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.005801_bib74","doi-asserted-by":"crossref","first-page":"42290","DOI":"10.1074\/jbc.M406284200","article-title":"The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1UP","volume":"279","author":"Riley","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005801_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2003.12.055","article-title":"Degradation properties of polyglutamine-expanded human androgen receptor in transfected cells","volume":"357","author":"Cullen","year":"2004","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.RA118.005801_bib76","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/hmg\/11.5.515","article-title":"Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy","volume":"11","author":"Bailey","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5638","article-title":"Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23","volume":"5","author":"Blount","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA118.005801_bib78","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1471-4159.2007.04460.x","article-title":"p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome","volume":"101","author":"Wang","year":"2007","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.005801_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuint.2016.12.019","article-title":"Polyglutamine expansion of ataxin-3 alters its degree of ubiquitination and phosphorylation at specific sites","volume":"105","author":"Kristensen","year":"2017","journal-title":"Neurochem. Int"},{"key":"10.1074\/jbc.RA118.005801_bib80","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2014.01.180","article-title":"Cycloheximide inhibits starvation-induced autophagy through mTORC1 activation","volume":"445","author":"Watanabe-Asano","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA118.005801_bib81","first-page":"69","article-title":"Effect of cycloheximide on induced autophagy in epithelial cells of the seminal vesicle of mice","volume":"22","author":"Kov\u00e1cs","year":"1974","journal-title":"Acta Morphol. Acad. Sci. Hung"},{"key":"10.1074\/jbc.RA118.005801_bib82","first-page":"100","article-title":"Regression of rat liver autophagic vacuoles by locally applied cycloheximide","volume":"54","author":"Papadopoulos","year":"1986","journal-title":"Lab. Invest"},{"key":"10.1074\/jbc.RA118.005801_bib83","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1242\/jcs.105.2.473","article-title":"Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes","volume":"105","author":"Lawrence","year":"1993","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.RA118.005801_bib84","first-page":"133","article-title":"Occurrence and inhibition by cycloheximide of apoptosis in vinblastine-treated murine pancreas: a role for autophagy?","volume":"42","author":"R\u00e9z","year":"1991","journal-title":"Acta Biol. Hung"},{"key":"10.1074\/jbc.RA118.005801_bib85","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1073\/pnas.1521919112","article-title":"mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005801_bib86","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/BJ20061854","article-title":"Transient arrest in proteasomal degradation during inhibition of translation in the unfolded protein response","volume":"404","author":"Shenkman","year":"2007","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA118.005801_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/823597","article-title":"A critical appraisal of quantitative studies of protein degradation in the framework of cellular proteostasis","volume":"2012","author":"Alvarez-Castelao","year":"2012","journal-title":"Biochem. Res. Int"},{"key":"10.1074\/jbc.RA118.005801_bib88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/pro.2520","article-title":"Double trouble: buffer selection and His-tag presence may be responsible for nonreproducibility of biomedical experiments","volume":"23","author":"Majorek","year":"2014","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.RA118.005801_bib89","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","article-title":"Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila","volume":"93","author":"Warrick","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.005801_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ng0696-196","article-title":"Expanded polyglutamine in the Machado\u2013Joseph disease protein induces cell death in vitro and in vivo","volume":"13","author":"Ikeda","year":"1996","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib91","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","article-title":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3","volume":"28","author":"Todi","year":"2009","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.005801_bib92","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.005801_bib93","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/40153","article-title":"Ataxin-1 with an expanded glutamine tract alters nuclear matrix- associated structures","volume":"389","author":"Skinner","year":"1997","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.005801_bib94","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","article-title":"Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length","volume":"4","author":"Becher","year":"1998","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.410440216","article-title":"Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy","volume":"44","author":"Li","year":"1998","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib96","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7","article-title":"Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer\u2019s disease and spinocerebellar ataxia 2","volume":"45","author":"Huynh","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.RA118.005801_bib97","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/7.5.913","article-title":"Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions","volume":"7","author":"Holmberg","year":"1998","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib98","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2010.01.005","article-title":"Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models","volume":"38","author":"H\u00fcbener","year":"2010","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA118.005801_bib99","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/pmic.200700038","article-title":"A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes","volume":"7","author":"Gloeckner","year":"2007","journal-title":"Proteomics"},{"key":"10.1074\/jbc.RA118.005801_bib100","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1038\/sj.onc.1207540","article-title":"A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway","volume":"23","author":"Brignone","year":"2004","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA118.005801_bib101","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nbt.2517","article-title":"A library of TAL effector nucleases spanning the human genome","volume":"31","author":"Kim","year":"2013","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.RA118.005801_bib102","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nmeth.1733","article-title":"Surrogate reporters for enrichment of cells with nuclease-induced mutations","volume":"8","author":"Kim","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA118.005801_bib103","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1093\/hmg\/ddp381","article-title":"Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3","volume":"18","author":"Boy","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.005801_bib104","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA118.005801_bib105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1756-0500-3-294","article-title":"REAP: a two minute cell fractionation method","volume":"3","author":"Suzuki","year":"2010","journal-title":"BMC Res. Notes"},{"key":"10.1074\/jbc.RA118.005801_bib106","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nprot.2009.36","article-title":"A practical guide to the MaxQuant computational platform for silac-based quantitative proteomics","volume":"4","author":"Cox","year":"2009","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA118.005801_bib107","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA118.005801_bib108","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2017"},{"key":"10.1074\/jbc.RA118.005801_bib109","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/bioinformatics\/btq046","article-title":"EBImage: an R package for image processing with applications to cellular phenotypes","volume":"26","author":"Pau","year":"2010","journal-title":"Bioinformatics"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820403783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820403783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.005801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:46:44Z","timestamp":1720799204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820403783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0021925820403783"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.005801","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiological and pathophysiological characteristics of ataxin-3 isoforms","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.005801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Weish\u00e4upl et al.","name":"copyright","label":"Copyright"}]}}